An evidence synthesis approach to estimating the incidence of seasonal influenza in the Netherlands

Influenza and other Respiratory Viruses

Volumn 8, Issue 1, 2014, Pages 33-41

  Mcdonald, Scott A ^a   Presanis, Anne M ^b   De Angelis, Daniela ^b   Van der Hoek, Wim ^a   Hooiveld, Mariette ^c   Donker, Gé ^c   Kretzschmar, Mirjam E ^a,d  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Bayesian evidence synthesis; Incidence; Seasonal influenza; Vacciation

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BAYESIAN LEARNING; CHILD; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; GENERAL PRACTITIONER; HUMAN; INCIDENCE; INFLUENZA VACCINATION; MIDDLE AGED; NETHERLANDS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEASONAL INFLUENZA; SENTINEL SURVEILLANCE; SYMPTOMATIC INFECTION ATTACK RATE; YOUNG ADULT;

BAYESIAN EVIDENCE SYNTHESIS; INCIDENCE; SEASONAL INFLUENZA; VACCIATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NETHERLANDS; YOUNG ADULT;

EID: 84890859886     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12201     Document Type: Article

References (20)

1. Molinari NA, Ortega-Sanchez IR, Messonnier ML et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007; 25:5086-5096. Epub 2007/06/05.
2. Meier CR, Napalkov PN, Wegmuller Y, Jefferson T, Jick H. Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis 2000; 19:834-842. Epub 2001/01/11.
3. Presanis AM, De Angelis D, Hagy A et al. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med 2009; 6:e1000207. Epub 2009/12/10.
4. Presanis AM, Pebody RG, Paterson BJ et al. Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis. BMJ 2009; 2011:d5408. Epub 2011/09/10.
5. Statistics Netherlands (CBS). The Population of the Netherlands by Age and Sex. Voorburg, NL: CBS, 2012. Available at http://statline.cbs.nl/ (Accessed 24 July 2012).
6. Donker GA. Continuous Morbidity Registration at Dutch Sentinel General Practice Network 2011. Utrecht: NIVEL, Netherlands Institute for Health Services Research, 2012.
7. Steens A, Waaijenborg S, Teunis PF et al. Age-dependent patterns of infection and severity explaining the low impact of 2009 influenza A (H1N1): evidence from serial serologic surveys in the Netherlands. Am J Epidemiol 2009; 2011:1307-1315. Epub 2011/10/26.
8. Donker GA. Continuous Morbidity Registration Sentinel Stations the Netherlands 2010. Utrecht: Nivel, 2011.
9. Dijkstra F, Donker GA, Wilbrink B, Van Gageldonk-Lafeber AB, Van Der Sande MA. Long time trends in influenza-like illness and associated determinants in The Netherlands. Epidemiol Infect 2009; 137:473-479. Epub 2008/09/16.
10. Friesema IH, Koppeschaar CE, Donker GA et al. Internet-based monitoring of influenza-like illness in the general population: experience of five influenza seasons in The Netherlands. Vaccine 2009; 27:6353-6357. Epub 2009/10/21.
11. Presanis AM, De Angelis D, Goubar A, Gill ON, Ades AE. Bayesian evidence synthesis for a transmission dynamic model for HIV among men who have sex with men. Biostatistics 2011; 12:666-681. Epub 2011/04/29.
12. Statistics Netherlands (CBS). Influenza Vaccination by Age, Sex And Risk Group. [Griepvaccinatie naar leeftijd, geslacht en risicogroep]. Voorburg, NL: CBS, 2011. Available at: http://statline.cbs.nl/(Accessed 24 July 2012).
13. Jansen B, Tacken M, Mulder J, Visscher S, Tiersma W, Braspenning J. Monitoring Vaccination Rates: Dutch National Influenza Prevention Programme 2010 [Monitoring vaccinatiegraad: Nationaal Programma Grieppreventie 2010]. Nijmegen: LINH, 2011.
14. Lunn D, Spiegelhalter D, Thomas A, Best N. The BUGS project: Evolution, critique and future directions. Stat Med 2009; 28:3049-3067. Epub 2009/07/25.
15. Thomas A, O'Hara B, Ligges U, Sturtz S. Making BUGS Open. R News 2006; 6:12-17.
16. Mereckiene J, Cotter S, D'Ancona F et al. Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009. Euro Surveill 2010; 15:pii:19700. Epub 2010/11/23.
17. McDonald SA, van Lier A, Plass D, Kretzschmar ME. The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands. BMC Public Health 2012; 12:1046. Epub 2012/12/12.
18. Hoeymans N, Gommer AM, Poos MJJC. Mortality, Morbidity and Disease Burden for 56 Selected Disorders [Verloren levensjaren, ziekte en ziektelast voor 56 geselecteerde aandoeningen]. Volksgezondheid Toekomst Verkenning, Nationaal Kompas Volksgezondheid (Dutch Public Health Status and Forecast studies, National Compass of Public Health). Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu (RIVM), 2007.
19. Dijkstra F, van Gageldonk-Lafeber AB, Brandsema P et al. Annual Respiratory Diseases Report 2006/2007. [Jaarrapportage respiratoire infectieziekten 2006/2007]. Bilthoven: RIVM; 2007.
20. Presanis A, Spiegelhalter DJ, Seaman S, Goubar A, Ades AE. Conflicting evidence in a Bayesian synthesis of surveillance data to estimate human immunodeficiency virus prevalence. J R Stat Soc Ser A Stat Soc 2008; 171:915-937.